1610452-26-0

Basic information

• Product Name: {2-(4-chlorophenyl)-2-[4-(5,6,7,8-tetrahydro-pyrido[2.3-d]pyrimidin-4-yl)-piperazin-1-yl]-ethyl}-dimethylamine
• Synonyms: {2-(4-chlorophenyl)-2-[4-(5,6,7,8-tetrahydro-pyrido[2.3-d]pyrimidin-4-yl)-piperazin-1-yl]-ethyl}-dimethylamine
• CAS NO: 1610452-26-0
• Molecular Weight: 400.954
• Mol File: 1610452-26-0.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: {2-(4-chlorophenyl)-2-[4-(5,6,7,8-tetrahydro-pyrido[2.3-d]pyrimidin-4-yl)-piperazin-1-yl]-ethyl}-dimethylamine(CAS DataBase Reference)
• NIST Chemistry Reference: {2-(4-chlorophenyl)-2-[4-(5,6,7,8-tetrahydro-pyrido[2.3-d]pyrimidin-4-yl)-piperazin-1-yl]-ethyl}-dimethylamine(1610452-26-0)
• EPA Substance Registry System: {2-(4-chlorophenyl)-2-[4-(5,6,7,8-tetrahydro-pyrido[2.3-d]pyrimidin-4-yl)-piperazin-1-yl]-ethyl}-dimethylamine(1610452-26-0)

Safety Data

• Hazardous Substances Data: 1610452-26-0(Hazardous Substances Data)

Upstream product

• 444894-97-7 [2-(4-chloro-phenyl)-2-piperazin-1-yl-ethyl]-dimethyl-amine 
• 3771-95-7 4-chloro-5,6,7,8-tetrahydro-pyrido[2,3-d]pyrimidine 

Relevant articles and documents

NOVEL HETEROCYCLIC DERIVATIVES AS MODULATORS OF KINASE ACTIVITY

The invention provides novel imidazol-piperidinyl derivatives of the formula (I) in which R1, R2, W, X1, X2, X3, X4 and n have the meanings indicated in formula (I), and their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.